Why the new ePrivacy Regulation must be on your corporate radar

Now that the hype and fury regarding the new GDPR has died down, manufacturing and engineering companies will have to get their heads around another European Union edict by the end of 2018 or early 2019 ... in the shape of the ePrivacy Regulation (ePR)

picture of

Breaking News

Codex Nutrition Committee to address excessive workload with new prioritisation process

The highly influential Codex Alimentarius Committee on Nutrition has agreed to develop a new prioritisation process to ...

OptiBiotix receives CE mark approval for SlimBiome weight management product

OptiBiotix Health has announced that its award-winning weight management product, SlimBiome, has been granted CE mark ...

BI achieves ISO/IEC 17025:2017 laboratory accreditation

BI, a global full-service manufacturer of plant-based ingredients, announces the successful completion of its ISO/IEC ...

HFSS food ads: key takeaways from the ASA's latest rulings

The ASA has had a positive flurry of activity on high fat, salt or sugar (HFSS) food ads, delivering rulings in no less ...

Dietary reference values: interactive tool goes live

EFSA has launched an interactive tool that allows nutritionists and other health professionals to make quick and easy ...

Unfulfilled promises: an industry need for an ethical label standard

The case of vitamin K2: a symptom of a wider challenge

Dioxins and related PCBs

Tolerable intake level updated

First dietary fibre verified natural according to ISO

Major chicory root processor Sensus announces that their full range of chicory inulin and oligofructose products ...

The trial of nutraceuticals

In recent years, food ingredient and nutraceutical manufacturers have increased their appetite for substantiating ...

Food safety plans: risk based preventive controls

Julie A. Brickel, MPH, Toxicologist at Burdock Group Consultants, discusses food safety plans and the various types of ...

Study finds effect of Valensa’s Zanthin on breast cancer cells

The journal, Antioxidants, has published a foundational paper in breast cancer research, finding Astaxanthin ...

First prescription CBD from GW Pharma has restriction lowered

The US Drug Enforcement Administration’s decision to move Epidiolex to Schedule V was based on non-clinical and ...